Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2025-12-25 @ 9:48 PM
NCT ID:
NCT03245151
Group ID:
EG001
Title:
Phase 1: Lenvatinib 11 mg/m^2 + Everolimus 3 mg/m^2
Description:
Participants with recurrent or refractory solid tumors received lenvatinib 11 mg/m\^2, capsules, orally, once daily in combination with everolimus 3 mg/m\^2, tablets, orally, once daily in cycle 1 (each cycle was 28 days) until the occurrence of PD, clinical benefit, development of unacceptable toxicity leading to withdrawal from the study, study discontinuation or for a maximum of 18 cycles (each cycle was 28 days) whichever occurred first.
Deaths Number Affected:
14
Deaths Number At Risk:
None
Serious Number Affected:
12
Serious Number At Risk:
18
Other Number Affected:
18
Other Number At Risk:
18
Study:
NCT03245151
Results Section:
NCT03245151
Adverse Events Module:
NCT03245151